Company news

Hypha Labs, Inc. (OTC:FUNI) news

Hypha Labs, Inc. news releases on 6ix. Latest, Oct 5, 2026: Hypha Labs Targets Disruptive Mushroom Active Ingredient Production

View Hypha Labs, Inc. →

Press releases & updates

Hypha Labs Targets Disruptive Mushroom Active Ingredient Production

October 5, 2026

The Functional Mushroom Revolution Has Begun

July 27, 2026

Hypha Labs (OTCQB:FUNI) Sees State-by-State Psilocybin Reform Creating the Next Major Growth Opportunity

July 13, 2026

Hypha Labs Highlights Parallels Between Emerging Psychedelic Industry and Early Cannabis Market Expansion

June 4, 2026

Trump Psychedelic Executive Order Accelerates Industry Growth

April 27, 2026

Hypha Labs, Inc. (OTCQB:FUNI) Announces Partnership with Mycology Resources, LLC

April 9, 2026

Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics

October 1, 2025

Hypha Labs and Automated Technical Services (ATS) Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing

September 29, 2025

Hypha Labs Expands List of Functional Mushrooms Able to be Produced in its Revolutionary Mushroom Accelerator

August 11, 2025

Hypha Labs Provides Shareholder Update

July 28, 2025

Hypha Labs Files New Patent Application for Its Suite of Artificial Intelligence (AI) Techniques for Its Mushroom Accelerator

June 10, 2025

Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator

May 13, 2025

Emerging Markets Report: A Milestone for Mycelium

May 12, 2025

Hypha Labs Acquires State-of-the-Art HPLC Analytic Machine and Partners with Lucidity Systems for Advanced Autosampler Upgrade

May 1, 2025

New Mexico Governor Signs Bill Allowing for Psilocybin Use

April 8, 2025

Hypha Laboratories Retains Stockhouse for International Awareness Campaign

March 16, 2025

Emerging Markets Report: Breakthroughs & Bureaucracy

February 11, 2025

Hypha Laboratories Reports Significant Breakthrough for MicroPearls(TM) Yields

January 29, 2025

Hypha Laboratories Applauds Call for Regulatory Changes for Functional Mushrooms

January 27, 2025

Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls(TM) Prototypes

November 17, 2024

Emerging Markets Report: A Mushroom Monster in the Making

October 16, 2024

Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown

October 14, 2024

Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production

October 6, 2024

Hypha Labs, Inc. Reveals First Functional Mushroom Ingredient Array for Home and Commercial Production

September 29, 2024

Functional Mushroom Company Hypha Labs Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services

September 25, 2024

Hypha Labs, Inc. Releases Investor Presentation

September 22, 2024

Hypha Labs, Inc. Uplists to the OTCQB

September 15, 2024

OTC Markets Group Welcomes New OTCQB Companies – September 16

September 16, 2024

Hypha Labs' Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press

August 19, 2024

Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. (FUNI)

August 12, 2024

CORRECTION: Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production

July 19, 2024

CORRECTION: Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications

July 19, 2024

Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production

June 23, 2024

Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications

June 10, 2024

Hypha Labs Announces New Patent Filing

May 19, 2024

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

April 28, 2024

Hypha Labs Names Craig Ellins Chief Science Officer

April 28, 2024

Digipath Enters Psilocybin Industry and Changes Name

April 21, 2024

Hypha Labs, Inc. to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

April 17, 2024

Digipath Announces Record Earnings of $292,533 for Recent Quarter Ended June 30

August 28, 2023

Digipath, Inc. Signs Agreement to Sell the Assets of Its Lab Subsidiary

May 4, 2023

Digipath, Inc. Announces Revenue Increase of Almost 18% for the Fourth Quarter of Fiscal Year 2022

December 8, 2022

Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus

May 2, 2022

Digipath to Provide Product Testing for Redwood Cultivation Products, Including Mike Tyson’s New Ear Shaped Gummies, ‘Mike Bites’

April 4, 2022

Digipath Enters Into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti-Microbial Product for the Cannabis Industry

March 1, 2022

Digipath Announces Financial Results for Q1, 2022

February 15, 2022

Digipath Obtains Coveted Compliance Testing License for California Laboratory

February 9, 2022

Digipath Announces Results for the Fiscal Year 2021

January 4, 2022

EVIO Inc. Executes Letter of Intent to sell C3 Labs, LLC to Digipath, Inc.

December 7, 2021

Digipath Takes Over Management & Signs Letter of Intent to Acquire Majority Control of Steep Hill’s Licensed Northern California Lab from Evio Labs

December 7, 2021

Older →